SOLICI Trademark

Trademark Overview


On Monday, July 3, 2023, a trademark application was filed for SOLICI with the United States Patent and Trademark Office. The USPTO has given the SOLICI trademark a serial number of 79378223. The federal status of this trademark filing is REGISTERED as of Tuesday, August 20, 2024. This trademark is owned by Cambridge Healthcare Research Limited. The SOLICI trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Providing scientific and technological information, advice and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific research and analysis for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific and technological landscaping for the pharmaceutical, biopharmaceutical and medical device industries; quality control for others, namely, assessment and benchmarking of pharmaceutical, biopharmaceutical and medical device products; quality control for others, namely, researching, analysing and assessment of pharmaceutical, biopharmaceutical and medical device products for others; providing scientific information about pharmaceutical, biopharmaceutical and medical device products and companies; scientific research consulting, namely, preparing advice and reports on all the aforesaid

Providing business advice, information and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; providing business information about pharmaceutical, biopharmaceutical and medical device products and companies; market research for the pharmaceutical, biopharmaceutical and medical device industries; business research and market analysis for the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, strategic consulting and assistance with business decisions in the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, competitor landscaping, competitor monitoring, business competitive intelligence for the pharmaceutical biopharmaceutical and medical device industries; preparing reports on all the aforesaid
solici

General Information


Serial Number79378223
Word MarkSOLICI
Filing DateMonday, July 3, 2023
Status700 - REGISTERED
Status DateTuesday, August 20, 2024
Registration Number7477345
Registration DateTuesday, August 20, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2024

Trademark Statements


Goods and ServicesProviding scientific and technological information, advice and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific research and analysis for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific and technological landscaping for the pharmaceutical, biopharmaceutical and medical device industries; quality control for others, namely, assessment and benchmarking of pharmaceutical, biopharmaceutical and medical device products; quality control for others, namely, researching, analysing and assessment of pharmaceutical, biopharmaceutical and medical device products for others; providing scientific information about pharmaceutical, biopharmaceutical and medical device products and companies; scientific research consulting, namely, preparing advice and reports on all the aforesaid
Goods and ServicesProviding business advice, information and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; providing business information about pharmaceutical, biopharmaceutical and medical device products and companies; market research for the pharmaceutical, biopharmaceutical and medical device industries; business research and market analysis for the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, strategic consulting and assistance with business decisions in the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, competitor landscaping, competitor monitoring, business competitive intelligence for the pharmaceutical biopharmaceutical and medical device industries; preparing reports on all the aforesaid

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, September 8, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 8, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCambridge Healthcare Research Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameCambridge Healthcare Research Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameCambridge Healthcare Research Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, September 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 12, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, September 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 15, 2024ASSIGNED TO EXAMINER
Thursday, March 28, 2024NON-FINAL ACTION WRITTEN
Friday, March 29, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 16, 2024REFUSAL PROCESSED BY MPU
Wednesday, April 17, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024REFUSAL PROCESSED BY IB
Wednesday, May 15, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 4, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, November 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, February 8, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, February 10, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 12, 2025FINAL DISPOSITION PROCESSED
Wednesday, February 12, 2025FINAL DISPOSITION NOTICE SENT TO IB
Saturday, March 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, March 1, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, November 29, 2025NEW REPRESENTATIVE AT IB RECEIVED